Cellid Announces Two New Reference Designs for Next-Generation AR Glasses

Cellid Announces Two New Reference Designs for Next-Generation AR Glasses

Cutting-edge wireless AR glasses enabled by proprietary optical technology and the latest waveguide innovations TOKYO, Dec. 2, 2025 /PRNewswire/ -- Cellid Inc., a developer of displays and spatial recognition engines for next-generation AR glasses,...

Yuyu Pharma Announces Strategic Investment in Dalan Animal Health as Part of Accelerated Global Expansion in Animal Health

Yuyu Pharma Announces Strategic Investment in Dalan Animal Health as Part of Accelerated Global Expansion in Animal Health

SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ -- Yuyu Pharma announced today that it has completed a strategic investment in Dalan Animal Health, a U.S.-based biotechnology company advancing an innate immunity–based platform for developing vaccines...

TP Receives Frost & Sullivan's 2025 African Company of the Year Recognition for Excellence in the Outsourcing Industry

TP Receives Frost & Sullivan's 2025 African Company of the Year Recognition for Excellence in the Outsourcing Industry

TP recognized for advancing Africa's outsourcing landscape through its strategic integration of technology, emotional intelligence, and sustainable growth initiatives. SAN ANTONIO, Dec. 2, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to...

IMS Receives Frost & Sullivan's 2025 North America Technology Innovation Leadership Recognition for Connected and Telematics Insurance

IMS Receives Frost & Sullivan's 2025 North America Technology Innovation Leadership Recognition for Connected and Telematics Insurance

Recognized for driving innovation in connected insurance and telematics solutions, IMS demonstrates leadership in customer engagement, data-driven insights, and digital transformation SAN ANTONIO, Dec. 2, 2025 /PRNewswire/ -- Frost & Sullivan is...

InSkill Receives Frost and Sullivan's 2025 Global New Product Innovation Recognition for Its Industrial AI Copilot Platform

InSkill Receives Frost and Sullivan's 2025 Global New Product Innovation Recognition for Its Industrial AI Copilot Platform

The company is honored for advancing industrial performance with GenAI copilots that improve equipment uptime, boost worker productivity, and streamline knowledge capture across industrial operations. SAN ANTONIO, Dec. 2, 2025 /PRNewswire/ -- Frost...

Frost & Sullivan: Health Recovery Solutions Receives the 2025 North American Customer Value Leadership Recognition for Excellence in Patient-Centered Care Delivery

Frost & Sullivan: Health Recovery Solutions Receives the 2025 North American Customer Value Leadership Recognition for Excellence in Patient-Centered Care Delivery

Frost & Sullivan recognizes Health Recovery Solutions for delivering adaptable, outcomes-driven, technology-enabled longitudinal care models SAN ANTONIO, Dec. 2, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Health...

Health In Tech Announces Voluntary Extension of Lock-Up Period

Health In Tech Announces Voluntary Extension of Lock-Up Period

STUART, Fla., Dec. 2, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, today announced that its executive management team, vice presidents across functions, and Board of Directors...

PEPSICO® ANNOUNCES LANDMARK GLOBAL PARTNERSHIP WITH MERCEDES-AMG PETRONAS F1 TEAM FOR 2026

PEPSICO® ANNOUNCES LANDMARK GLOBAL PARTNERSHIP WITH MERCEDES-AMG PETRONAS F1 TEAM FOR 2026

Gatorade®, Sting®, and Doritos® unite performance, energy, and flavor with the eight-time FIA World Constructors' Champions PURCHASE, N.Y., Dec. 2, 2025 /PRNewswire/ -- Today, PepsiCo announces a landmark global partnership with Mercedes-AMG...

Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy

Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy

SHANGHAI and HONG KONG, Dec. 2, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class...

Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health

Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health

∇ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. LONDON, Dec. 2, 2025 /PRNewswire/ -- Accord Healthcare today announced the launch of Osvyrti (denosumab), a biosimilar to Prolia®...

  • 1
  • ...
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • ...
  • 145
  • menu
    menu